infohep
  • Menu
  • Search
  • Home
  • News
  • About hepatitis
  • Services
  • Countries
  • About us
  • Twitter
  • Facebook
  • RSS
  • Home
  • News
  • All the news

All the news

Showing 10 of 2,029 articles

Get an RSS feed of these articles

  • All news
  • infohep news
  • Editors' picks from other sources
  • Hepatocellular carcinoma (HCC)

    HCV-Related Liver Cancer Incidence Dropped in US Cohort

    Medscape / 28 September 2020

  • Coronavirus

    Govt rejects pharma giant Mylan’s proposal to test low-cost hepatitis drug combo against Covid

    The Print / 28 September 2020

  • Treatment guidelines

    EASL recommendations on treatment of Hepatitis C 2020

    EASL / 28 September 2020

  • NAFLD

    Novel methods of non-invasive testing for non-alcoholic fatty liver disease

    EASL / 28 August 2020

  • NAFLD

    Liver fibrosis assessment in routine care for diabetic patients could uncover a hidden population of people living with advanced liver disease

    EASL / 28 August 2020

  • Experimental treatments for NASH/NAFLD

    Two novel treatments show promise in improving biomarkers of NASH pathology

    EASL / 28 August 2020

  • Infection control in health facilities

    Updated CDC Guidance for Healthcare Personnel With Potential Exposure to HCV

    Infectious Disease Advisor / 24 August 2020

  • NAFLD

    Fatty Liver Disease Tied to Metabolic Health Conditions in People With HIV

    Poz / 24 August 2020

  • International Liver Congress 2021 dates announced

    EASL / 24 August 2020

  • Hepatitis C elimination

    COVID-19 leads to challenges ‘at every single step’ of HCV care cascade

    Healio / 18 August 2020

← Prev12345...203Next →
Other pages in this section
  • Latest news
  • All the news
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C
    • Hepatitis D
    • Hepatitis E
    • Coronavirus
    • NAFLD
    • Treatment for hepatocellular carcinoma
    • Transmission, epidemiology and prevention
    • Health services, policy and advocacy
    • Social issues
  • Conference news
  • Noticeboard
  • Email bulletins
  • News feeds

  • Contact us
  • Terms and conditions
  • Accessibility
  • Privacy and cookies

Latest hepatitis news

Sign-up for our monthly email bulletin Follow us on Twitter Find us on Facebook

The information on this website is intended to support, rather than replace, consultation with a healthcare professional.

©NAM Publications 2017. All rights reserved. We are not responsible for the content of external websites.

We are grateful to Abbvie, Janssen, Merck and Gilead for funding infohep.org. Our funders have had no editorial control over the site’s content.

infohep

Latest treatment news and information for patient advocates and people working in hepatitis in Europe.

NAM working with the World Hepatitis Alliance and the European Liver Patients Association

www.infohep.org/page//about-us/Find-out-about-NAM/page/2626330//   www.worldhepatitisalliance.org   www.elpa-info.org